World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
136
Citations
76172
World Ranking
1965
National Ranking
1116

Overview

Merrick I. Ross is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on the field of medicine, with a strong emphasis on oncology. The subfields associated with their work include oncology, molecular biology, immunology, pulmonary and respiratory medicine, and surgery.

The scientist's research spans several important topics in cancer and immunotherapy, including:

  • Cutaneous Melanoma Detection and Management
  • CAR-T Cell Therapy Research
  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Melanoma and MAPK Pathways
  • Virus-Based Gene Therapy Research
  • Cancer Research and Treatments

Merrick I. Ross has contributed to multiple recent academic papers, including:

  • "Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response", 2021, Science
  • "Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma", 2023, New England Journal of Medicine
  • "NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021", 2021, Journal of the National Comprehensive Cancer Network
  • "Neoadjuvant relatlimab and nivolumab in resectable melanoma", 2022, Nature
  • "Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trial", 2021, Nature Medicine

Frequent co-authors in Merrick I. Ross's publications include:

  • Jeffrey E. Gershenwald
  • Jennifer A. Wargo
  • Michael A. Davies
  • Rodabe N. Amaria
  • Sarah B. Fisher

The journals where Merrick I. Ross most often publishes include:

  • Journal of Clinical Oncology
  • Annals of Surgical Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Nature
  • Annals of Oncology

Best Publications

  • Final Version of 2009 AJCC Melanoma Staging and Classification

    Charles M. Balch;Jeffrey E. Gershenwald;Seng Jaw Soong;John F. Thompson

  • Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma

    Charles M. Balch;Antonio C. Buzaid;Seng-Jaw Soong;Michael B. Atkins

  • Genomic Classification of Cutaneous Melanoma

    Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert

  • Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

    Charles M. Balch;Seng-Jaw Soong;Jeffrey E. Gershenwald;John F. Thompson

  • Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

    Robert H.I. Andtbacka;Howard L. Kaufman;Frances Collichio;Thomas Amatruda

  • Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

    Jeffrey E. Gershenwald;Richard A. Scolyer;Kenneth R. Hess;Vernon K. Sondak

  • Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

    Henry M. Kuerer;Lisa A. Newman;Terry L. Smith;Fred C. Ames

  • Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.

    Jeffrey E. Gershenwald;William Thompson;Paul F. Mansfield;Jeffrey E. Lee

  • The orderly progression of melanoma nodal metastases.

    Douglas Reintgen;C. Cruse;Karen Wells;Claudia Berman

  • Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.

    Charles M. Balch;Seng Jaw Soong;Alfred A. Bartolucci;Marshall M. Urist

  • Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma

    Jason Chesney;Igor Puzanov;Frances Collichio;Parminder Singh

  • Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

    Rodabe N. Amaria;Sangeetha M. Reddy;Hussein A. Tawbi;Michael A. Davies

  • Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma

    John Albertini;C. Cruse;David Rapaport;Karen Wells

  • Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system

    Bianca D. Lemos;Barry E. Storer;Jayasri G. Iyer;Jerri Linn Phillips

  • Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.

    Jeffrey E. Gershenwald;Maria I. Colome;Jeffrey E. Lee;Paul F. Mansfield

  • Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)

    Charles M. Balch;Seng Jaw Soong;Merrick I. Ross;Marshall M. Urist

  • An Evidence‐based Staging System for Cutaneous Melanoma

    Charles M. Balch;Seng Jaw Soong;Michael B. Atkins;Antonio C. Buzaid

  • A new American Joint Committee on Cancer staging system for cutaneous melanoma.

    Charles M. Balch;Antonio C. Buzaid;Michael B. Atkins;Natale Cascinelli

  • Lymphedema beyond breast cancer

    Janice Nicole Cormier;Robert L. Askew;Kristi S. Mungovan;Yan Xing

  • Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases

    Charles M. Balch;Jeffrey E. Gershenwald;Seng Jaw Soong;John F. Thompson

Frequent Co-Authors

Jeffrey E. Gershenwald
Jeffrey E. Gershenwald The University of Texas MD Anderson Cancer Center
Jeffrey E. Lee
Jeffrey E. Lee The University of Texas MD Anderson Cancer Center
Henry Mark Kuerer
Henry Mark Kuerer The University of Texas MD Anderson Cancer Center
Kelly K. Hunt
Kelly K. Hunt The University of Texas MD Anderson Cancer Center
Janice N. Cormier
Janice N. Cormier The University of Texas MD Anderson Cancer Center
Barry W. Feig
Barry W. Feig The University of Texas MD Anderson Cancer Center
Paul F. Mansfield
Paul F. Mansfield The University of Texas MD Anderson Cancer Center
S. Eva Singletary
S. Eva Singletary The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam
Funda Meric-Bernstam The University of Texas MD Anderson Cancer Center
Gildy Babiera
Gildy Babiera The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine in the USA, there are several related online degrees and pathways to expand your qualifications or enter the healthcare field. For nurses seeking advanced leadership roles, msn to dnp programs online offer a flexible way to obtain a Doctor of Nursing Practice degree.

If your interests lean towards pharmacology, pursuing pharmacy school online allows you to access advanced pharmacy education remotely, opening doors to both clinical and research roles.

For those passionate about healthcare technology and management, an online health information management degree provides expertise in managing patient data, electronic records, and medical systems.

Additionally, administrative careers in healthcare are accessible through online medical billing and coding courses, equipping you with the skills to handle billing, insurance claims, and regulatory compliance.

These programs deliver high-quality education with the convenience of online learning, helping you build essential skills and open diverse career opportunities in the growing healthcare sector.

Best Scientists Citing Merrick I. Ross

Trending Scientists

Recently Published Articles